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Nursing  is  a  core  discipline  in  health  care  delivery.  Our
trial,  discussed  below,  has  provided  compelling  high  level
evidence  that  ‘careful  attention  to  aspects  of  nursing  and
general  care  appears  to  generate  large  benefits’  (Norrving,
2011).
Colleagues  and  I  recently  published  the  results  of  a
five  year  cluster  randomised  controlled  trial  in  the  Lancet.
Known  as  the  quality  in  acute  stroke  care  (QASC)  trial,  we
examined  the  effectiveness  of  a  multi-disciplinary  ‘bundled’
intervention  based  on  best  clinical  evidence  to  improve
outcomes  for  stroke  patients  (Middleton  et  al.,  2011). Our
intervention  consisted  of  nurse-initiated  clinical  treatment
protocols  to  manage  fever,  hyperglycaemia  and  swallowing.
The  fever  protocol  asked  nurses  to  monitor  patient  temper-
atures  four  to  six  hourly  and  treat  all  readings  ≥37.5 ◦C  with
paracetamol.  Our  hyperglycaemia  protocol  did  not  aim  to
tightly  control  glycaemic  levels  as  in  other  stroke  trials  (Gray
et  al.,  2007) but  to  treat  episodes  of  major  hyperglycaemia
(fingerprick  blood  glucose  levels  ≥11  mmol/L  for  diabetics
and  ≥16  mmol/L  for  non-diabetics).  Our  swallowing  proto-
col  consisted  of  educating  nurses  to  undertake  swallowing
screening,  with  referral  to  a  speech  pathologist  for  full  swal-
lowing  assessment  only  when  patients  failed  the  screen.
We  supported  the  introduction  of  the  treatment  protocols
into  the  clinical  setting  with  multidisciplinary  workshops  to
assess  barriers,  an  education  program  and  on-site  support;
all  aimed  at  harnessing  the  untapped  interest  of  clinicians
working  collectively  to  improve  clinical  outcomes.  Nineteen
stroke  units  participated  and  we  collected  outcome  data
from  1696  patients.
Excitingly,  we  found  that  patients  cared  for  in  the  ten
stroke  units  who  received  our  intervention  were  16%  more
likely  to  be  alive  and  independent  90  days  following  their
stroke  than  those  cared  for  in  the  nine  stroke  units  ran-
domised  to  the  control  group  who  received  only  an  abridged
copy  of  the  national  stroke  guidelines  (National  Stroke
Foundation,  2007). This  is  a  large  effect;  larger  than  that
of  any  pharmacological  (Hacke  et  al.,  2008) or  organisa-
tional  initiative  (Stroke  Unit  Trialists  Collaboration,  1997)
currently  known  to  improve  outcomes  following  stroke.
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lucose  levels  and  improved  screening  for  swallowing  dif-
culties  (Middleton  et  al.,  2011).
As  is  the  way  with  randomised  controlled  trials  (RCTs),
owever,  more  questions  were  raised  than  answered.  RCTs
nswer  only  the  specific  question(s)  they  were  designed  to
nswer:  in  our  case,  does  a  bundled  intervention  premised
n  genuine  interdisciplinary  collaboration  in  the  stroke  unit
ignificantly  improve  outcomes?  What  RCTs  do  not  explain  is
ow  the  intervention  in  question  worked.  Our  results  have
enerated  great  interest  in  the  stroke  community  and  spec-
lation  about  how  this  large  effect  may  have  been  achieved
Norrving,  2011;  Wolfe  and  Rudd,  2011;  Alberts  et  al.,  2011).
To  explore  the  ‘how’  of  our  results,  we  conducted  a  pro-
ess  analysis  alongside  our  main  trial  in  order  to  ‘study
nnovation  at  the  same  time  it  is  occurring  and  collect  data
o  link  new  interventions  to  outcomes’  (Dixon-Woods  et  al.,
011)  Dixon  Woods  also  exhorts  that  researchers  should  ‘not
ait  until  the  trial  is  complete  before  working  out  what
s  needed  to  adopt  and  implement  the  intervention  in  real
ife’ (Dixon-Woods  et  al.,  2011). In  other  words,  when  an
ntervention  is  shown  in  trial  conditions  to  deliver  results,
ata  also  should  be  available  to  inform  clinicians  how  to  inte-
rate  these  new  practices  into  routine  hospital  care.  Results
f  our  process  analysis  are  pending  but  will  provide  key  data
o  explain  further  our  trial  results.
One  very  thought  provoking  possibility  already  has
een  raised  in  the  post-publication  response  to  our  trial
Norrving,  2011;  Dixon-Woods  et  al.,  2011), in  his  com-
entary,  suggested  that  our  study  ‘raise[s]  the  question  of
hether  the  interventions  .  . .  are  merely  surrogate  markers
or  better  overall  care’. He  goes  on  to  note  that  clinicians
who  are  more  attentive  to  swallowing  issues,  control  of
levated  blood  sugars,  and  aggressive  evaluation  of  fevers
ay  provide  better  care  through  any  number  of  processes
nd  mechanisms,  which  may  then  translate  into  better  90-
ay  outcomes’  (Alberts  et  al.,  2011) This  is  an  explanation
orthy  of  consideration.  Is  it  possible  that,  whilst  attendinghe  patient  to  take  their  temperature,  record  their  blood
lucose  levels  and  assess  their  swallowing,  clinicians  may
ave  picked  up  other  early  signs  of  deterioration?  These







































































other  treatments’  were  not  of  direct  relevance  to  our  trial
nd  so  were  not  measured  by  us.  Further  analyses  of  our
rocess  of  care  results  will  illuminate  the  role  of  fever,
lucose  and  swallowing  management  and  their  impact  on
atient  outcomes.
What  we  do  know,  is  that,  regardless  of  exactly  how
he  intervention  worked,  it  did  work  and  with  a  resounding
ffect.  Our  trial  is  one  of  the  few  studies  published  inter-
ationally  to  show  that  nursing  care  can  improve  the  hard
ndpoints  of  death  and  dependency.  Our  treatment  proto-
ols  were  evidence-based,  highly  pragmatic  and  bolstered
he  delivery  of  good  clinical  care  deserved  by  every  patient.
hus,  our  trial  provides  high-level  evidence  on  the  value  of
oing  the  simple  things  well.  Neither  expensive  technology
or  resource  intensive  initiatives  were  required.  What  was
equired  was  attention  to  what  nurses  do  best,  observing
he  patient  and  initiating  prompt  treatment.  That  our  inter-
ention  was  based  upon  nurse-led  clinical  protocols  that
nabled  them  to  promptly  treat  patients  also  bodes  well  for
ore  efficient  and  timely  nurse-initiated  patient  care  going
orward.
One  of  the  other  important  lessons  learnt  as  a  result  of
his  trial  was  that,  prior  to  commencement  of  our  trial,
any  nurses  told  us  that  they  already  were  managing  fever,
yperglycaemia  and  swallowing  for  their  stroke  patients  in
ine  with  best  evidence  and  according  to  the  national  stroke
uidelines  (National  Stroke  Foundation,  2007). Our  pre-
ntervention  data  shows  this  not  to  be  the  case  (Drury  et  al.,
010).  Unless  we  audit  our  current  practice,  we  cannot  be
ure  of  our  treatment  gaps.  We  should  not  assume  evidence-
ased  ‘best  practice’  is  being  delivered  to  all  patients,  by
very  nurse,  on  every  shift.  Only  until  this  is  the  case  will
e  achieve  the  population  outcomes  patients  deserve,  be
hat  for  stroke  patients  or  otherwise.
Importantly  too,  this  trial  also  shows  the  pivotal  role  of
ursing  academics  in  conducting  implementation  research.
ptake  of  our  clinical  protocols  was  facilitated  by  an
vidence-based  implementation  strategy  (multidisciplinary
orkshops  to  identify  barriers,  education  and  on-site  sup-
ort)  (Grimshaw  et  al.,  2004). Our  trial  has  provided  further
vidence  for  the  effectiveness  of  these  implementation
trategies  in  changing  clinician  behavior.  This  element  of
ur  trial  likely  is  highly  transferable  to  other  clinical  areas
nd  settings  beyond  stroke.
While  this  trial  is  an  example  of  nurse-led  multidis-
iplinary  research,  it  could  not  have  been  undertaken
ithout  the  support  from  the  multidisciplinary  stroke
eam,  specifically  doctors  and  speech  pathologists.  That
peech  pathologists  embraced  nurses  undertaking  swallow-
ng  screening  is  testament  to  good  collaborative  practice
imed  at  improving  patient  outcomes.
Our  stroke  care  collaboration  has  now  received  additional
HMRC  funding  to  further  examine  facilitation  of  multidis-
iplinary  collaborative  evidence-based  stroke  care  led  by
urses  in  emergency  departments  in  three  Australian  states.
hile  this  will  be  a  challenging  project,  involving  up  to
8  hospitals  across  three  states,  it  will  build  on  our  pre-
ious  trial  discussed  here  and  we  hypothesise  that  it  also
ill  provide  further  compelling  evidence  of  the  high  impactEditorial
hat quality  nursing  care  can  have  on  our  often  beleaguered
ealthcare  system.
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